Literature DB >> 1715560

Structural and functional domains in human tumour necrosis factors.

C R Goh1, A G Porter.   

Abstract

Human tumour necrosis factors (hTNFs) alpha and beta are related pleiotropic cytokines which share many activities and compete with each other for binding to two receptor components on many cell types. Although structural and biological data indicate that the active form of hTNF-alpha may be a symmetrical trimer, the manner in which hTNFs interact with their receptors to trigger a myriad of cell type-dependent responses is not clear. A combination of chemical modification, epitope mapping and site-directed mutagenesis approaches suggest that at least four distinct peptide sequences are important for the biological activity of hTNF-alpha. In particular, certain peptide sequences between amino acid positions 11 and 35 in hTNF-alpha appear to be critical for receptor binding and triggering biological responses. The recent cloning of the two hTNF-alpha/beta receptors opens the way for precise mapping of the functional domains in hTNFs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715560     DOI: 10.1093/protein/4.4.385

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  5 in total

Review 1.  Development of novel drug delivery systems using phage display technology for clinical application of protein drugs.

Authors:  Kazuya Nagano; Yasuo Tsutsumi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2016       Impact factor: 3.493

2.  Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions.

Authors:  Ivana Nemčovičová; Chris A Benedict; Dirk M Zajonc
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

3.  The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.

Authors:  H Tchorzewski; K Zeman; J Kantorski; E Paleolog; M Kahan; M Feldmann; M Kwinkowski; P Guga; B Szymanska; P Parniewski; A Wilk; J Jarosz
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

4.  A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice.

Authors:  K Warzocha; J Góra-Tybor; M Kwinkowski; B Szymańska; T Robak
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

5.  Porphyromonas gingivalis downregulates the immune response of fibroblasts.

Authors:  Eleonor Palm; Hazem Khalaf; Torbjörn Bengtsson
Journal:  BMC Microbiol       Date:  2013-07-10       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.